Safeguard Scientifics, Inc. (SFE), a provider of growth capital for technology and life sciences companies, reported Thursday a wider loss for the fourth quarter, despite a 78% rise in revenues.
The Wayne, Pennsylvania-based company's quarterly net loss widened to $19.39 million or $0.16 per share from $15.52 million or $0.13 per share in the previous year. Net loss from continuing operations was $19.39 million or $0.16 per share, compared to $11.91 million or $0.10 per share in the earlier year.
Revenues for the quarter grew to $21.94 million from $12.36 million in the preceding year.
Operating expenses increased to $26.57 million from $20.81 million last year.
For the full year, the company posted net loss of $52.01 million or $0.42 per share, compared to net loss of $65.87 million or $0.54 per share in the previous year. Loss from continuing operations narrowed to $42.78 million or $0.35 per share from $46.48 million or $0.38 per share a year ago.
Revenues for the year increased to $73.73 million from $42.99 million in the earlier year.
In 2008, Safeguard repurchased 974,900 shares of its common stock at an average price of $1.31 per share.
SFE closed Wednesday's regular trading at $0.42 on the NYSE.
For comments and feedback contact: editorial@rttnews.com
June 12, 2026 17:14 ET Major central bank action was the focus this week in economic news. The European Central Bank became the first major central bank to move in response to the rising inflationary pressures in the backdrop of the conflict in the Middle East. In North America, the U.S. inflation and trade data as well as Canada’s central bank decision gained attention. The Chinese trade data was the main news in Asia.